Cargando…

Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy

Misfolding mutations in cartilage oligomeric matrix protein (COMP) cause it to be retained within the endoplasmic reticulum (ER) of chondrocytes, stimulating a multitude of damaging cellular responses including ER stress, inflammation, and oxidative stress, which ultimately culminates in the death o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hecht, Jacqueline T, Coustry, Francoise, Veerisetty, Alka C, Hossain, Mohammad G, Posey, Karen L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990140/
https://www.ncbi.nlm.nih.gov/pubmed/33778324
http://dx.doi.org/10.1002/jbm4.10456
_version_ 1783669020312993792
author Hecht, Jacqueline T
Coustry, Francoise
Veerisetty, Alka C
Hossain, Mohammad G
Posey, Karen L
author_facet Hecht, Jacqueline T
Coustry, Francoise
Veerisetty, Alka C
Hossain, Mohammad G
Posey, Karen L
author_sort Hecht, Jacqueline T
collection PubMed
description Misfolding mutations in cartilage oligomeric matrix protein (COMP) cause it to be retained within the endoplasmic reticulum (ER) of chondrocytes, stimulating a multitude of damaging cellular responses including ER stress, inflammation, and oxidative stress, which ultimately culminates in the death of growth plate chondrocytes and pseudoachondroplasia (PSACH). Previously, we demonstrated that an antioxidant, resveratrol, substantially reduces the intracellular accumulation of mutant‐COMP, dampens cellular stress, and lowers the level of growth plate chondrocyte death. In addition, we showed that resveratrol reduces mammalian target of rapamycin complex 1 (mTORC1) signaling, suggesting a potential mechanism. In this work, we investigate the role of autophagy in treatment of COMPopathies. In cultured chondrocytes expressing wild‐type COMP or mutant‐COMP, resveratrol significantly increased the number of Microtubule‐associated protein 1A/1B‐light chain 3 (LC3) vesicles, directly demonstrating that resveratrol‐stimulated autophagy is an important component of the resveratrol‐driven mechanism responsible for the degradation of mutant‐COMP. Moreover, pharmacological inhibitors of autophagy suppressed degradation of mutant‐COMP in our established mouse model of PSACH. In contrast, blockage of the proteasome did not substantially alter resveratrol clearance of mutant‐COMP from growth plate chondrocytes. Mechanistically, resveratrol increased SIRT1 and PP2A expression and reduced MID1 expression and activation of phosphorylated protein kinase B (pAKT) and mTORC1 signaling in growth plate chondrocytes, allowing clearance of mutant‐COMP by autophagy. Importantly, we show that optimal reduction in growth plate pathology, including decreased mutant‐COMP retention, decreased mTORC1 signaling, and restoration of chondrocyte proliferation was attained when treatment was initiated between birth to 1 week of age in MT‐COMP mice, translating to birth to approximately 2 years of age in children with PSACH. These results clearly demonstrate that resveratrol stimulates clearance of mutant‐COMP by an autophagy‐centric mechanism. © 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.
format Online
Article
Text
id pubmed-7990140
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-79901402021-03-25 Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy Hecht, Jacqueline T Coustry, Francoise Veerisetty, Alka C Hossain, Mohammad G Posey, Karen L JBMR Plus Original Articles Misfolding mutations in cartilage oligomeric matrix protein (COMP) cause it to be retained within the endoplasmic reticulum (ER) of chondrocytes, stimulating a multitude of damaging cellular responses including ER stress, inflammation, and oxidative stress, which ultimately culminates in the death of growth plate chondrocytes and pseudoachondroplasia (PSACH). Previously, we demonstrated that an antioxidant, resveratrol, substantially reduces the intracellular accumulation of mutant‐COMP, dampens cellular stress, and lowers the level of growth plate chondrocyte death. In addition, we showed that resveratrol reduces mammalian target of rapamycin complex 1 (mTORC1) signaling, suggesting a potential mechanism. In this work, we investigate the role of autophagy in treatment of COMPopathies. In cultured chondrocytes expressing wild‐type COMP or mutant‐COMP, resveratrol significantly increased the number of Microtubule‐associated protein 1A/1B‐light chain 3 (LC3) vesicles, directly demonstrating that resveratrol‐stimulated autophagy is an important component of the resveratrol‐driven mechanism responsible for the degradation of mutant‐COMP. Moreover, pharmacological inhibitors of autophagy suppressed degradation of mutant‐COMP in our established mouse model of PSACH. In contrast, blockage of the proteasome did not substantially alter resveratrol clearance of mutant‐COMP from growth plate chondrocytes. Mechanistically, resveratrol increased SIRT1 and PP2A expression and reduced MID1 expression and activation of phosphorylated protein kinase B (pAKT) and mTORC1 signaling in growth plate chondrocytes, allowing clearance of mutant‐COMP by autophagy. Importantly, we show that optimal reduction in growth plate pathology, including decreased mutant‐COMP retention, decreased mTORC1 signaling, and restoration of chondrocyte proliferation was attained when treatment was initiated between birth to 1 week of age in MT‐COMP mice, translating to birth to approximately 2 years of age in children with PSACH. These results clearly demonstrate that resveratrol stimulates clearance of mutant‐COMP by an autophagy‐centric mechanism. © 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2021-01-22 /pmc/articles/PMC7990140/ /pubmed/33778324 http://dx.doi.org/10.1002/jbm4.10456 Text en © 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Hecht, Jacqueline T
Coustry, Francoise
Veerisetty, Alka C
Hossain, Mohammad G
Posey, Karen L
Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy
title Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy
title_full Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy
title_fullStr Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy
title_full_unstemmed Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy
title_short Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy
title_sort resveratrol reduces compopathy in mice through activation of autophagy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990140/
https://www.ncbi.nlm.nih.gov/pubmed/33778324
http://dx.doi.org/10.1002/jbm4.10456
work_keys_str_mv AT hechtjacquelinet resveratrolreducescompopathyinmicethroughactivationofautophagy
AT coustryfrancoise resveratrolreducescompopathyinmicethroughactivationofautophagy
AT veerisettyalkac resveratrolreducescompopathyinmicethroughactivationofautophagy
AT hossainmohammadg resveratrolreducescompopathyinmicethroughactivationofautophagy
AT poseykarenl resveratrolreducescompopathyinmicethroughactivationofautophagy